AIMT Articles, Aimmune Therapeutics Inc.
home / stock / aimt / aimt articles
-
Over the past twenty days of trading, Aimmune Therapeutics Inc. (NASDAQ: AIMT), from November 01, 2019 to November 29, 2019 there is a potential Sh...
Aimmune Therapeutics Inc. Company Name:
AIMT Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
DBV Technologies (NASDAQ: DBVT) , a biopharmaceutical company based in France, provided a business update today regarding Viaskin, a potential peanut allergy treatment the company developed that is currently being reviewed by the U.S. Food and Drug Administration (FDA). DBV Technologies expre...
-
Aimmune Therapeutics (NASDAQ: AIMT) has performed significantly worse than the broader market of late. The company's stock fell by more than 50% during the first quarter of the year, and even though it has rebounded somewhat, Aimmune's shares are still down by 43% year to date. If Aimmune ca...
-
BioCryst Pharmaceuticals Goes Ahead with Expanded Access Program for Berotralstat BioCryst Pharmaceuticals Inc. ( BCRX ) announced launching its Expanded Access Program for berotralstat. The program will allow physicians to request the drug for hereditary angioedema patients who do not h...
